Outbound investment deal value in pharmaceutical sector from Hong Kong 2016-2019
In 2019, Hong Kong's pharmaceutical sector completed two outbound investment deals, as publicly disclosed, with a total value of about 93 million U.S. dollars. It was a significant increase compared to the previous two years, yet still much lower than the level in 2016.